Molecular Mechanism of the Asarum–Angelica Drug Pair in the Treatment of Periodontitis Based on Network Pharmacology and Experimental Verification
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417389 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qianyang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endodontics and Periodontics, College of Stomatology, Dalian Medical University, 9 West Section, Lvshun South Road, Dalian 116044, Chin…. Hauptthemen laut MEDLINE: Asarum, Angelica, Periodontitis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Plan of Liaoning Province, Provincial Basic Scientific Research Project of Liaoning Education Department.
Abstract (Originalsprache)
(1) To examine the potential mechanism of the Asarum–Angelica drug pair against periodontitis and provide an experimental basis for the treatment of periodontitis with herbal medicine. (2) The core components and core targets of the Asarum–Angelica drug pair in the treatment of periodontitis were detected according to network pharmacology methods. Finally, the effect of the Asarum–Angelica drug pair on osteogenic differentiation was observed in mouse embryonic osteoblast precursor cells. (3) According to the results of network pharmacology, there are 10 potential active ingredients in the Asarum–Angelica drug pair, and 44 potential targets were obtained by mapping the targets with periodontitis treatment. Ten potential active ingredients, such as kaempferol and β-sitosterol, may play a role in treating periodontitis. Cell experiments showed that the Asarum–Angelica drug pair can effectively promote the expression of osteoblast markers alkaline phosphatase (ALP), Runt-related Transcription Factor 2 (RUNX2), and BCL2 mRNA and protein in an inflammatory environment (p < 0.05). (4) Network pharmacology effectively analyzed the molecular mechanism of Asarum–Angelica in the treatment of periodontitis, and the Asarum–Angelica drug pair can promote the differentiation of osteoblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endodontics and Periodontics, College of Stomatology, Dalian Medical University, 9 West Section, Lvshun South Road, Dalian 116044, China.
- Academician Laboratory of Immune and Oral Development and Regeneration, Dalian Medical University, Dalian 116044, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Plan of Liaoning Province
- Provincial Basic Scientific Research Project of Liaoning Education Department
- Liaoning Province Doctor Startup Fund Funded
- Dalian Science and Technology Innovation Fund
Zitieren
APA
Chen, Q., Wang, Y., Shi, C., Tong, M., Sun, H., Dong, M., Liu, S., & Wang, L. (2023). Molecular Mechanism of the Asarum–Angelica Drug Pair in the Treatment of Periodontitis Based on Network Pharmacology and Experimental Verification. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417389
Vancouver
Chen Q, Wang Y, Shi C, Tong M, Sun H, Dong M, et al. Molecular Mechanism of the Asarum–Angelica Drug Pair in the Treatment of Periodontitis Based on Network Pharmacology and Experimental Verification. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417389
BibTeX
@article{Chen2023,
author = {Chen, Qianyang and Wang, Yuhan and Shi, Chun and Tong, Meichen and Sun, Haibo and Dong, Ming and Liu, Shuo and Wang, Lina},
title = {Molecular Mechanism of the Asarum–Angelica Drug Pair in the Treatment of Periodontitis Based on Network Pharmacology and Experimental Verification},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417389}
}
EUVIMED